JAVMA news
Board debates policy points on medicinal products
Thorny issues surrounding the appropriate use of medicinal products—and how to handle adverse events—prompted discussion during the Executive Board…
JAVMA news
Four flea, tick products linked to seizures, ataxia
Four flea and tick products may cause seizures, tremors, and lost coordination in some cats and dogs.
JAVMA news
FDA warns that compounding clenbuterol is illegal
In recent years, the availability of illegal clenbuterol formulations, produced as "compounded" drug product, has
JAVMA news
Horse deaths associated with unapproved drug
An unapproved clenbuterol product associated with two horse deaths in Louisiana has prompted the FDA to remind veterinarians and horse
JAVMA news
Topical gels: An option for panicky pill takers?
There are over 100 drugs advertised as products that can be administered topically to veterinary patients
JAVMA news
DEA provides update on opioid shortage
The Drug Enforcement Administration released a statement April 10 on the ongoing opioid shortages affecting both human and veterinary medicine.
JAVMA news
Frustration mounts over opioid shortage
Drug shortages and discontinuations are nothing new to veterinary medicine.
JAVMA news
Reminder: ECP not approved for use in animals
The Food and Drug Administration's Center for Veterinary Medicine has received reports that certain pharmacies and veterinarians have compounded…
blog
AVMA working group helps navigate opioid abuse epidemic
An AVMA working group has taken up the task of providing needed information to help veterinary professionals contribute productively to the national…
JAVMA news
FDA to enhance pharmaceutical good manufacturing practices
The Food and Drug Administration announced an initiative to enhance the regulation of pharmaceutical manufacturing
blog
DEA provides update on opioid shortage
The U.S. Drug Enforcement Administration (DEA) released a statement last week on the ongoing opioid shortages affecting both human and veterinary…
JAVMA news
Cannabis research for veterinary patients advancing, cautiously
More than half the country has legalized marijuana use in one form or another.
JAVMA news
The truth about serum
The anesthesia team is transfusing the patient with plasma believed to contain normal to high protein concentrations.
JAVMA news
Nitrofuran ban in effect
The AVMA reminds veterinarians that the Food and Drug Administration has prohibited all uses of nitrofuran drugs
blog
Wellbeing in the veterinary workplace: Collaboration and culture are key
President’s Column: Dr. John de Jong In the workplace, wellbeing plays an important role in determining not only individual health and happiness, but…
JAVMA news
FDA may change drug uses in 5-year plan
Federal authorities plan to expand limits on who can buy antimicrobials for use in livestock and how long they can be used.
policy
Joint AVMA-FVE-CVMA statement on continuous monitoring of antimicrobial use and antimicrobial resistance
The AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association endorse this statement on continuous monitoring of…
JAVMA news
Options available to protect against longhorned tick
The invasive longhorned (bush) tick, Haemaphysalis longicornis, has been a growing concern for the veterinary community following the appearance of…
JAVMA news
Monograph on macrocyclic lactones released
The U.S. Pharmacopeia has released a free monograph on macrocyclic lactones.
JAVMA news
Foundation announces recipients of new research grants
The American Veterinary Medical Foundation recently announced the recipients of new research grants in pharmacology and pain management in dogs.
JAVMA news
Internet pharmacies and compounding are high-priority areas, FDA says
Posted on March 1, 2002 Since prior coverage on the issue of Internet pharmacies (see JAVMA, June 1, 2001, and Aug. 15, 2001), the AVMA continues…
JAVMA news
Final guidance on anthelmintics use available
The Food and Drug Administration has issued three final guidance documents regarding the use of anthelmintics
JAVMA news
Buprenorphine rescheduled under stricter regulatory control
The Drug Enforcement Administration has rescheduled buprenorphine from a schedule V narcotic to a schedule III narcotic
JAVMA news
FDA seeks comment on Animal Drug User Fee Act
The Food and Drug Administration is seeking comment on the Animal Drug User Fee Act regarding the program's performance and reauthorization.
JAVMA news
FDA to allow more drugs for nonfood minor species
The Food and Drug Administration is proposing regulations to implement the index of Legally Marketed Unapproved New Animal Drugs for Minor Species"…